08 March 2018
The Hong Kong Stock Exchange has proposed the biggest overhaul of its IPO listing rules in over twenty years, including allowing dual class-listing and favorable listing terms for biotech companies. These changes are expected to make the HKEX the most attractive overseas listing option for mainland Chinese firms, and potentially help Hong Kong reclaim its leading position on the global IPO league table.
At the same time, after a record 437 IPOs in mainland China, raising a total of RMB45 billion last year, the outlook for domestic IPOs by Chinese companies is increasingly uncertain as the regulatory approval process becomes more strenuous. That should spark greater interests by Chinese companies, especially those in biotech sector, to seek a public share float in the neighboring Special Administrative Region, Hong Kong.
Taking The World Public – IPO Event Series: Shanghai 2018, to be hosted on 24th April 2018 by China Money Network in conjunction with Baker Tilly Hong Kong and our supporting partner InvestHK, will examine these issues and more, providing an exclusive venue for both business leaders and investors to take the pulse of the IPO market in Greater China.
Secure your seat today for the most anticipated IPO discussion of the year!
Date: Tuesday, April 24, 2018
Location: JW Marriott Shanghai (Tomorrow Square)
Language: This event will be conducted in Mandarin Chinese
ONC Lawyers: Partner, Angel Wong
Angel Wong is a partner at ONC Lawyers, building up the firm’s IPO practice during the past ten years. She specializes in corporate finance and has advised many listing applicants and sponsors in initial public offerings (IPOs) on the Main Board and GEM Board of the Hong Kong Stock Exchange. She has rich experience in pre-IPO restructuring and financing, overseas listing, mergers and acquisitions, loan and financing transactions, corporate governance and general compliance for listed companies as well as private enterprises.
CDH Investment: Partner, Lily Zhang
Lily Zhang joined CDH Investments in 2015 focused on healthcare industry investments, with rich experience in investing in the biotech industry. Previously, she worked as director of Business Development and Intelligence at GlaxoSmithKline (China) Investment, and business development manager of Asia Pacific at Johnson & Johnson, responsible for merger and acquisition deals in the treatment sector.
JunHe LLP: Senior Partner, Chunyang Shao
Chunyang Shao joined JunHe in 2002 as a partner, and has since acted as PRC counsel for the issuer or the underwriter for IPOs and domestic or offshore listings of PRC conglomerates or high-growth companies. He has also represented various multinational corporations and investment funds on their investments and mergers and acquisitions in China. In recent years, Mr. Shao has represented PRC companies of PE funds in their offshore investments or cross-border M&A projects.
Baker Tilly Hong Kong: Director of Risk Advisory, Doman Wong
Mr. Wong has 30 years of experience combining external audit, management accounting, operations management, and internal audit and investigation. First trained in one of the Big Four accounting firms, he has held management positions in a number of listed companies, including Asian subsidiaries of US and UK multi-national companies based in Hong Kong and Australia. He is actively involved in the management and development of Baker Tilly’s Risk Advisory Department, overseeing the performance of internal control review assignments, IT system review, corporate governance review, enterprise risk assessment as well as fraud investigation assignments.
China Money Network: Managing Editor, Nina Xiang
Nina Xiang is the co-founder and managing editor overseeing editorial content and product development at China Money Network. Before founding China Money Network in 2011, she worked at BusinessWeek magazine in Beijing and Institutional Investor magazine in New York, covering business and financial services in China and the U.S. While in New York, she also served as part-time correspondent for Shanghai’s financial television channel China Business Network, as well as China Radio International, China’s national English-language radio network.
10:00am Guest Registration
10:30am Welcome and Keynote address
10:45am Panel Discussion
11:45am Q&A with audience
12:00pm: Lunch & Networking
* This event will be conducted in Mandarin Chinese
Gain Forward-Looking Intelligence & Find Opportunities for your Business at our Taking The World Public – IPO Event Series: Shanghai 2018
For any inquiries, please contact: firstname.lastname@example.org